Where does Alentis Therapeutics's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Alentis Therapeutics's 2 recorded funding rounds.

Premier Alternatives

Alentis Therapeutics

Drug Discovery · Allschwil, Switzerland · Founded 2019 · Privately Held (backing)

Operator of a clinical-stage biopharmaceutical company intended to offer various treatments for cancer and fibrotic diseases. Alentis Therapeutics is based in Allschwil, Switzerland and was founded in 2019. It has raised $362 million across 2 recorded rounds; the latest was an $181 million Series D in Nov 2024.

Last price · $/share

—

Implied valuation

—

Total raised

$362.5M

Last round

Later Stage VC (Series D)

Nov 2024

Cap table — not yet on record

Alentis Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Alentis Therapeutics with a free account

·The complete investor list: 21 names
·Watch Alentis Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Alentis Therapeutics

Where does Alentis Therapeutics's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Alentis Therapeutics's 2 recorded funding rounds.